 |
DEPARTMENT OF REGULATORY PLANNING AND STRATEGY
The Department of Regulatory Planning and Strategy ("DRPS" or the "Department") was created in 2004 to improve the Member and Regulatory Services Division's (the "Division") ability to efficiently address regulatory changes in relation to the evolving trading environment. DRPS acts as the Division's liaison to the Systems Division in the development of automated surveillance and also serves as the Division's liaison to the Legal Division to evaluate the regulatory impact of proposed rule filings. The Department also represents the Exchange's regulatory interests at certain membership committees both to facilitate communications with the regulatory staff and to communicate the impact of proposed Exchange rules. DPRS is also responsible for responding to SEC inquiries and inspection reports regarding the regulatory program and implementing or facilitating progress toward CBOE commitments to the SEC, Regulatory Oversight Committee and CBOE Board of Directors. The Department also works to enhance member services and communication through the development and distribution of Regulatory Circulars and addressing suggestions, concerns and complaints received from members and investors regarding regulatory issues.
If you would like further information about DRPS, please call (312) 786-7834.
|
|
Options involve risk and are not suitable for all
investors. Prior to buying or selling an option, a person must receive a copy
of Characteristics and Risks of Standardized
Options (ODD). Copies of the ODD are available from your broker, by
calling 1-888-OPTIONS, or from The Options Clearing Corporation, One North
Wacker Drive, Suite 500, Chicago, Illinois 60606. The information on this
website is provided solely for general education and information purposes and
therefore should not be considered complete, precise, or current. Many of the
matters discussed are subject to detailed rules, regulations, and statutory
provisions which should be referred to for additional detail and are subject to
changes that may not be reflected in the website information. No statement
within the website should be construed as a recommendation to buy or sell a
security or to provide investment advice. The inclusion of non-CBOE
advertisements on the website should not be construed as an endorsement or an
indication of the value of any product, service, or website. The
Terms and Conditions govern use of this website and use of this website
will be deemed acceptance of those Terms and Conditions.
|
|